Program: Education Program
Session: A Map for the Changing Landscape of CLL
Hematology Disease Topics & Pathways:
Biological, antibodies, Diseases, Therapies, Non-Hodgkin Lymphoma, immunotherapy, Lymphoid Malignancies, Clinically relevant
Session: A Map for the Changing Landscape of CLL
Hematology Disease Topics & Pathways:
Biological, antibodies, Diseases, Therapies, Non-Hodgkin Lymphoma, immunotherapy, Lymphoid Malignancies, Clinically relevant
Saturday, December 5, 2020, 7:25 AM-7:30 AM
Disclosures: Mato: Adaptive: Consultancy, Research Funding; AstraZeneca: Consultancy, Research Funding; LOXO: Consultancy, Research Funding; BeiGene: Consultancy; Pharmacyclics LLC, an AbbVie Company: Consultancy, Research Funding; AbbVie: Consultancy, Research Funding; TG Therapeutics: Consultancy, Other: DSMB, Research Funding; Genentech: Consultancy, Research Funding; Janssen: Consultancy, Research Funding.
<< Previous Presentation
|
Next Presentation